Booming Triangle sector has nearly 24,500 workers, up 4 percent year-over-year – List Insights
Date Published:
One of the Triangle’s more prominent subsets in its burgeoning life sciences is contract research. And this area has become…
Life Sciences
Why this company picked NC for a $110 million investment
Date Published:
A San-Fransisco gene therapy company knew it wanted a new base outside of California, and it says the Triangle is…
Study: Thousands of biopharma jobs coming to NC by 2024; average wage $97,575
Date Published:
RESEARCH TRIANGLE PARK – North Carolina is widely known for its job-ready biopharma manufacturing workforce. And the newly published 2020…
Biotech startup Arrevus receives FDA orphan drug designation for cystic fibrosis treatment
Date Published:
RALEIGH — Biotech startup Arrevus is one step closer to potentially extending the lifespans of those living with cystic fibrosis…
The Triangle’s big slice of NC bio/pharma pie – List Insights
Date Published:
The life sciences industry is no doubt big business in North Carolina with more than 735 bioscience companies and a…
Duke spinout Polarean exceeds expectations with lung-imaging trial, seeks meeting with FDA
Date Published:
A successful Phase 3 trial of Polarean Imaging’s drug-device combination for lung imaging has the Research Triangle Park company poised…
NC State, biopharma company developing gene therapy for asthma
Date Published:
NEW YORK, N.Y. — Biopharmaceutical company Hoth Therapeutics has tapped NC State to collaborate and carry out a preclinical study…
NC Biotech CEO Doug Edgeton: ‘We will lead science behind curative gene, cell therapies”
Date Published:
RESEARCH TRIANGLE PARK — For the better part of four decades, North Carolina has steadily committed resources to developing biotechnologies…
bluebird bio launches gene therapy for severe blood disorder in Germany
Date Published:
DURHAM — bluebird bio, a gene therapy company with operations in Durham, has launched for the first time its treatment…